W E TR AN S FO R M YO U R M O LE CU LE I NTO A R EG I STE R E D D R UG Debiopharm’s core activities consist in:

First Page		Document Content
Date: 2013-06-03 04:06:57 Biopharmaceuticals Debiopharm Fertility medicine Gonadotropin-releasing hormone agonist Pharmaceutical industry Oxaliplatin Gonadotropin-releasing hormone Pharmaceutical drug Triptorelin Chemistry Pharmacology Pharmaceutical sciences		W E TR AN S FO R M YO U R M O LE CU LE I NTO A R EG I STE R E D D R UG Debiopharm’s core activities consist in: Add to Reading List Source URL: www.debiopharm.com Download Document from Source Website File Size: 585,29 KB Share Document on Facebook

	Microsoft Word - DSU Degarelix FINAL sent to NICE DocID: 1oZJA - View Document
	Zmeny v Zozname zakázaných látok 2016 Trvalo zakázané látky a metódy S2. Peptidové hormóny, rastové faktory, príbuzné látky a mimetiká Leuprorelín nahradil triptorelín ako univerzálnejší príklad ch DocID: 1n149 - View Document
	High doses of triptorelin needed for ovarian suppression in SLE DocID: 1ddi4 - View Document
	Microsoft Word - About Ferring - fact sheet_31Mar15.doc DocID: 143Ql - View Document
	AUSTRALIAN PESTICIDES & VETERINARY MEDICINES AUTHORITY Application Summary for Application No[removed]Application Details: Product Name: DocID: VB1H - View Document